Across the competition policy landscape, many are jostling for vantage over GenAI—a scramble laid bare in the ICN sessions in Edinburgh last week and, at the same moment, in the remedies phase of US v Google. In Europe, it was the German Verbraucherzentrale that dropped the first pebble, swiftly followed by NOYB, and the ripples carry particular weight in the shadow of the Court’s 2023 Meta ruling—a fact of which Meta is, needless to say, acutely aware.
[More soon in a paper].
